Ear Acupuncture for Addicted Pregnant Women
http://7thspace.com/headlines/428916/auricular_acupuncture_for_chemically_dependent_pregnant_women_a_randomized_controlled_trial_of_the_nada_protocol.html
The prevalence of maternal drug use during pregnancy in North America has been estimated to be as high as 6-10%. The consequences for the newborn include increased risk for perinatal mortality and ongoing physical, neurobehavioral, and psychosocial problems.
Methadone is frequently used to wean women off street drugs but is implicated as a cause of adverse fetal/neonatal outcomes itself. The purpose of our study was to test the ability of maternal acupuncture treatment among mothers who use illicit drugs to reduce the frequency and severity of withdrawal symptoms among their newborns.
Methods: We randomly assigned chemically dependent pregnant women at BC Women’s Hospital in Vancouver, British Columbia to daily acupuncture treatments versus usual care.
By necessity, neither our participants nor acupuncturists were blinded as to treatment allocation. Our primary outcome was days of neonatal morphine treatment for symptoms of neonatal withdrawal.
Secondary neonatal outcomes included admission to a neonatal ICU and transfer to foster care.
Results: We randomized 50 women to acupuncture and 39 to standard care. When analyzed by randomized groups, we did not find benefit of acupuncture; the average length of treatment with morphine for newborns in the acupuncture group was 2.7 (6.3) compared to 2.8 (7.0) in the control group.
Among newborns of women who were compliant with the acupuncture regime, we observed a reduction of 2.1 and 1.5 days in length of treatment for neonatal abstinence syndrome compared to the non-compliant and control groups, respectively. These differences were not statistically significant.
Conclusions: Acupuncture may be a safe and feasible treatment to assist mothers to reduce their dosage of methadone.
Our results should encourage ongoing studies to test the ability of acupuncture to mitigate the severity of neonatal abstinence syndrome among their newborns.Clinical Trial Registrationhttp: www.clinicaltrials.gov registry: W05-0041
Author: Patricia JanssenLouise C DemorestAnne KellyPaul ThiessenRon Abrahams
Credits/Source: Substance Abuse Treatment, Prevention, and Policy 2012, 7:48